With the guidance of a healthcare provider, setting a monthly weight loss goal can help you stay on track and keep you ...

In what Guggenheim Partners called one of Metsera’s “critical program milestones” this year, its ultra-long-acting amylin ...

Metsera links long-acting GLP-1 shot to 7.5% weight loss at 36 days, mulls monthly dosing The monthly ... or overweight is fully enrolled and on track to deliver data around the middle of 2025.

While rapid weight loss might seem appealing, it often comes with risks that can outweigh the benefits. Understanding the safe limit for monthly weight loss is essential for achieving sustainable ...

Metsera has linked its amylin analog to 8.4% placebo-adjusted weight loss at Day 36, advancing its push to develop an ...

Amgen's (AMGN) once-monthly GLP-1, which experts expect to be a game changer in the weight-loss space, is showing continued promise as it advances in clinical trials. The company reported 20% ...